Hints and tips:
...US, Federal Open Market Committee makes interest rate announcement with officials signalling a 75 basis point rise Results: Airbus H1, BASF Q2, Boeing Q2, Breedon H1, Bristol Myers Squibb Q2, British...
...Pharmaceutical company earnings Drugmaker Bristol-Myers Squibb is scheduled to report fourth-quarter results and is expected to post a higher profit than last year on increased sales of its cancer drugs...
...From the pharmaceuticals sector, Bristol-Myers Squibb — which recently agreed to buy Celgene in one of the largest pharmaceutical deals in history — reports....
...The two banks have landed on some of the biggest deals of the year, with JPMorgan advising on the $90bn tie-up between Bristol-Myers Squibb and Celgene and Goldman providing advice to Allergan on its $85bn...
...Bristol-Myers Squibb, a mammoth US drugmaker on the brink of completing a $90bn merger with Celgene — one of the largest in pharma history — is Starboard’s latest target....
International Edition